# Immuneering Corp: Form DEF 14A, filed May 1, 2023

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: DEF 14A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 07:28 ET
- Period: 2023-05-01
- Accession: 0001790340-23-000011
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000179034023000011/immuneeringcorporationproxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000179034023000011/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000179034023000011/immuneeringcorporationproxy.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001790340-23-000011. Last ingested by Listed: Nov 10, 2026, 03:06 ET. No prices; not investment advice.
